Infographics

The WHO-led Epidemic Intelligence from Open Sources (EIOS) training program equips public health specialists to strengthen Botswana’s public health infrastructure. In the ever-evolving landscape of public health, timely and accurate health emergency monitoring is a vital resource to track and respond to outbreaks. 

The Regional Office for Africa (AFRO), WHO Geneva in collaboration with WHO Namibia and the Ministry of Health and Social Services conducted a training on Global Antimicrobial Resistance (AMR) and Use surveillance system (GLASS) and WHONET tool in Windhoek, for 12 selected member states. The training aimed to build capacity of Member States to establish and/or enhance national surveillance systems for AMR and generate, collect, report, and use quality data to inform decisions at the country, regional and global levels.  

In a bid to strengthen global health security, the World Health Organization (WHO) has concluded a comprehensive assessment of Angola's readiness and response to health threats. This initiative, the Joint External Evaluation (JEE), took place between 25th and 29th September 2023.

The Yellow Fever sub-national risk analysis findings dissemination workshop, and consultative and advocacy meeting was held in Addis Ababa Ethiopia on 4th October 2023. The workshop was organized by World Health Organization (WHO) Ethiopia in collaboration with Ministry of Health (MoH) and global and in-country partners. 

Luanda, 24^th of October, 2023 ‒ In the neighborhood of Caope Velha, in the municipality of Cacuaco in Luanda, Elisa António de Melo, 70, is carrying a baby girl in her arms. She is waiting with her two granddaughters and four great-grandchildren for the polio vaccine to be administered to the children.

Abuja, 24 October 2023 – Nigeria today introduced the human papillomavirus (HPV) vaccine into its routine immunization system, aiming to reach 7.7 million girls – the largest number in a single round of HPV vaccination in the African region – in a vaccination drive against the virus that causes nearly all cases of cervical cancer. 

Girls aged 9–14 years will receive a single dose of the vaccine, which is highly efficacious in preventing infection with HPV types 16 and 18 that are known to cause at least 70% of cervical cancers. 

In the early afternoon of 9 September, Catarino Francisco is coordinating the work of 12 monitors in the urban district of Ngola Kiluanje, whose task is to monitor the level of implementation of the polio vaccination campaign to the target group of children under five years.